Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

23,712articles mentioning diseases

125,551disease mentions

18,081distinct diseases extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted diseases

Showing 4,201–4,260 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.

Orthorexia nervosa2 Osteogenesis imperfecta (OI)2 Osteonecrosis of the femoral head (ONFH)2 Ovarian vein thrombophlebitis2 PDS2 POD2 PS2 PTS2 Pancreatic neuroendocrine tumors2 Penetrating cardiac injury2 Penile cancer (PeCa)2 Peptic ulcers2 Peripheral eosinophilia2 Peripheral nerve injury2 Peripheral neuropathic pain2 Periprosthetic joint infections2 Pheochromocytomas2 Phrenic nerve block2 Placenta accreta spectrum2 Plasmodium falciparum2 Platinum resistant ovarian cancer2 Platypnoea–orthodeoxia syndrome2 Pleuroparenchymal fibroelastosis2 Polyendocrine metabolic ovarian syndrome (PMOS)2 Porto-sinusoidal vascular disorder2 Post-cardiac arrest syndrome (PCAS)2 Post-dural puncture headache (PDPH)2 Post-streptococcal glomerulonephritis2 Posterior circulation strokes2 Postherpetic neuralgia (PHN)2 Postoperative ileus2 Postoperative sleep disturbance (PSD)2 Primary angiitis of the central nervous system2 Primary breast angiosarcoma2 Primary headache disorders2 Primary lateral sclerosis2 Progressive multifocal leucoencephalopathy2 Progressive multifocal leukoencephalopathy (PML)2 Protracted bacterial bronchitis (PBB)2 Psoriatic arthritis (PsA)2 Pulmonary Artery Hypertension (PAH)2 Pulmonary arteriovenous malformations (PAVMs)2 Pulmonary capillary haemangiomatosis2 Pyogenic liver abscess2 RMDs2 Recurrent glioblastoma2 Recurrent respiratory papillomatosis (RRP)2 Recurrent urinary tract infections2 Renal Transplant2 Restrictive lung disease2 Retinal neurodegeneration2 Road traffic injuries2 Road traffic injuries (RTIs)2 Ruptured intracranial aneurysms (RIAs)2 SARS-CoV-192 SID2 SLE-derived2 SLEDAS2 SLEMethods2 SMA12

View all 18,081 diseases on one page

Articles mentioning diseases

23,712 articles · page 273 of 1976

415 Treatment patterns of systemic therapies in extensive-stage small-cell lung cancer (ES-SCLC): a real-world observational study

jitc · abstract · 2025-11-04 · 9 matching annotations

96.7%

ES-SCLC small cell lung cancer tarlatamab atezolizumab durvalumab Merck Sharp & Dohme LLC carboplatin

…ons This study showed that while more than 70% of patients with ES-SCLC received ICI-containing regimens as first-line treatment, progn…

431 Immune checkpoint inhibitor for advanced cutaneous malignancies in organ transplant recipients: a case series from a single center experience

jitc · abstract · 2025-11-04 · 9 matching annotations

97.8%

Merkel cell carcinoma cutaneous malignancy melanoma squamous cell carcinoma cutaneous malignancies sirolimus Inova Schar Cancer Institute everolimus prednisone mycophenolate+4 more

…gnancies including melanoma, squamous cell carcinoma (SCC), and Merkel cell carcinoma (MCC). However, the concurrent use of ICIs and immunosuppressan…

435 ES038, a novel NKCE molecule targeting LILRB4 in AML via dual engagement of NKG2A and NKG2C

jitc · abstract · 2025-11-04 · 9 matching annotations

93.5%

AML Acute myeloid leukemia ES038 LILRB4

…es NK cell activation and improves their therapeutic potential. AML, particularly in relapsed or refractory cases, remains a signif…

463 Dissecting myeloid-driven mechanisms of immunotherapy resistance in prostate cancer bone metastases

jitc · abstract · 2025-11-04 · 9 matching annotations

94.4%

metastatic castration-resistant prostate cancer mCRPC pancreatic ductal carcinoma prostate cancer ipilimumab enzalutamide J Clin Oncol Atezolizumab

…al. Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. Nat Med. 2022;28:144–53.Koo KC, Pa…

546 Sarilumab as a potential mitigator of ubamatamab (MUC16×CD3)-induced cytokine release syndrome (CRS) in patients with advanced ovarian cancer (OC) or endometrial cancer (EC)

jitc · abstract · 2025-11-04 · 9 matching annotations

96.0%

CRS OC recurrent advanced OC sarilumab ubamatamab

…4.Conclusions A single sarilumab dose before ubamatamab reduced CRS incidence and severity. Pharmacokinetic and pharmacodynamic fin…

640 CHS-114, an anti-CCR8 cytolytic monoclonal antibody demonstrates selective intratumoral Treg depletion and favorable immune remodeling in participants with advanced solid tumors

jitc · abstract · 2025-11-04 · 9 matching annotations

93.5%

head and neck squamous cell carcinoma advanced solid tumors HNSCC CHS-114

…ansion study is evaluating CHS-114 in advanced solid tumors and head and neck squamous cell carcinoma (HNSCC). CHS-114 has demonstrated an acceptable safety profile …

651 Imneskibart, a human monoclonal antibody (mAb) that binds IL-2 and prevents CD25 binding, + low-dose subcutaneous IL-2: phase 2 update on CPI-refractory melanoma and non-small cell lung cancer (NSCLC)

jitc · abstract · 2025-11-04 · 9 matching annotations

99.3%

Melanoma NSCLC Imneskibart Avelumab

…or regressions and a low incidence of Grade 3/4 adverse events. Melanoma patients with primary resistance to prior doublet immune checkp…

675 Radiopharmaceutical therapy enhances CAR T-cell activity against neuroblastoma by tumor sensitization and tumor microenvironment remodeling

jitc · abstract · 2025-11-04 · 9 matching annotations

94.4%

neuroblastoma solid tumors hematological malignancies SK-N-AS NB [67Cu]Cu-LLP2A [ 67Cu]Cu-LLP2A 67Cu]Cu-LLP2A NIH institutional IACUC RPT

…ell therapy remains less effective against solid tumors such as neuroblastoma (NB) than hematological malignancies. Key obstacles for CAR T c…

679 Combined radiation and adoptive CTL therapy in advanced extramammary paget disease with pulmonary and nodal metastases: a case report and rationale for case series expansion

jitc · abstract · 2025-11-04 · 9 matching annotations

92.6%

melanoma-specific Extramammary Paget’s disease (EMPD)EMPD melanoma solid tumors EBV-related cancers IL-2 Radiother Oncol Adoptive CTL therapy Proc Natl Acad Sci USA+1 more

…:62-68.Chapuis AG, Ragnarsson GB, Nguyen HN, et al. Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire cen…

708 Overcoming resistance to chemo-immunotherapy in non-small cell lung cancer by targeting adenosine metabolism and enhancing CD8+ T cell activation

jitc · abstract · 2025-11-04 · 9 matching annotations

93.5%

NSCLC non-small cell lung cancer A375 melanoma NSCLC-bearing cisplatin carboplatin cisplatin-induced cisplatin-treated PEG-ADA

… NSCLC cells. For T cell suppression assays, M-MDSCs from human NSCLC were cultured with autologous T cells stimulated with anti-CD3 …

725 Fertility concerns and outcomes among adolescent and young adult males with melanoma receiving immunotherapy

jitc · abstract · 2025-11-04 · 9 matching annotations

97.9%

melanoma microsatellite instability-high (MSI-H) tumors University of Michigan Immune checkpoint inhibitors ICIs first-line immunotherapy

…reatment, toxicity, and fertility characteristics of young male melanoma patients treated with immune checkpoint inhibitors (n=38)…

776 Melanoma tumor cells and immunotherapy cooperatively reprogram bone marrow niches to induce early hematopoietic dysfunction and therapy-related myeloid neoplasms

jitc · abstract · 2025-11-04 · 9 matching annotations

99.6%

Melanoma myelodysplastic syndromes therapy-related myeloid neoplasms immune checkpoint inhibitors immune checkpoint inhibitor therapy Embase PubMed Scopus

…rrow niche alterations and hematopoietic clonal dynamicsResults Melanoma tumor cells infiltrate the bone marrow early, with disseminated…